Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2009;105:639-647
Published online before print August 27, 2009, doi: 10.1161/CIRCRESAHA.109.205120
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
105/7/639    most recent
CIRCRESAHA.109.205120v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Spiekerkoetter, E.
Right arrow Articles by Rabinovitch, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spiekerkoetter, E.
Right arrow Articles by Rabinovitch, M.
Related Collections
Right arrow Pulmonary biology and circulation
Right arrow Smooth muscle proliferation and differentiation
Right arrow Pulmonary circulation and disease
(Circulation Research. 2009;105:639.)
© 2009 American Heart Association, Inc.


Molecular Medicine

S100A4 and Bone Morphogenetic Protein-2 Codependently Induce Vascular Smooth Muscle Cell Migration via Phospho–Extracellular Signal-Regulated Kinase and Chloride Intracellular Channel 4

Edda Spiekerkoetter, Christophe Guignabert, Vinicio de Jesus Perez, Tero-Pekka Alastalo, Janine M. Powers, Lingli Wang, Allan Lawrie, Noona Ambartsumian, Ann-Marie Schmidt, Mark Berryman, Richard H. Ashley, Marlene Rabinovitch

From the Department of Pediatrics (E.S., C.G., V.d.J.P., T.-P.A., J.M.P., L.W., M.R.), Stanford University School of Medicine, Calif; School of Medicine and Biomedical Sciences (A.L.), University Sheffield, United Kingdom; Danish Cancer Society (N.A.), Copenhagen, Denmark; Department of Physiology (A.-M.S.), Medicine and Surgery, Columbia University, New York; Department of Biomedical Sciences (M.B.), Ohio University College of Osteopathic Medicine, Athens; and Centre for Integrative Physiology (R.H.A.), University of Edinburgh Medical School, United Kingdom.

Correspondence to Dr Marlene Rabinovitch, The Vera Moulton Wall Center for Pulmonary Vascular Disease, Stanford University School of Medicine, CCSR Bldg, Room 2245b, 269 Campus Dr, Stanford, CA 94305-5162. E-mail marlener{at}stanford.edu

Rationale: S100A4/Mts1 is implicated in motility of human pulmonary artery smooth muscle cells (hPASMCs), through an interaction with the RAGE (receptor for advanced glycation end products).

Objective: We hypothesized that S100A4/Mts1-mediated hPASMC motility might be enhanced by loss of function of bone morphogenetic protein (BMP) receptor (BMPR)II, observed in pulmonary arterial hypertension.

Methods and Results: Both S100A4/Mts1 (500 ng/mL) and BMP-2 (10 ng/mL) induce migration of hPASMCs in a novel codependent manner, in that the response to either ligand is lost with anti-RAGE or BMPRII short interference (si)RNA. Phosphorylation of extracellular signal-regulated kinase is induced by both ligands and is required for motility by inducing matrix metalloproteinase 2 activity, but phospho–extracellular signal-regulated kinase 1/2 is blocked by anti-RAGE and not by BMPRII short interference RNA. In contrast, BMPRII short interference RNA, but not anti-RAGE, reduces expression of intracellular chloride channel (CLIC)4, a scaffolding molecule necessary for motility in response to S100A4/Mts1 or BMP-2. Reduced CLIC4 expression does not interfere with S100A4/Mts1 internalization or its interaction with myosin heavy chain IIA, but does alter alignment of myosin heavy chain IIA and actin filaments creating the appearance of vacuoles. This abnormality is associated with reduced peripheral distribution and/or delayed activation of RhoA and Rac1, small GTPases required for retraction and extension of lamellipodia in motile cells.

Conclusions: Our studies demonstrate how a single ligand (BMP-2 or S100A4/Mts1) can recruit multiple cell surface receptors to relay signals that coordinate events culminating in a functional response, ie, cell motility. We speculate that this carefully controlled process limits signals from multiple ligands, but could be subverted in disease.


Key Words: bone morphogenetic protein • S100 protein • vascular smooth muscle cells • intracellular chloride channel • migration